Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Recent & Breaking News (NYSE:PFE)

Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility

Business Wire May 20, 2013

The Straight Truth, Investing in GRPN, INTC and PFE

Marketwired May 18, 2013

Finding the Next Big Blockbuster Drug

Accesswire May 16, 2013

Strategy Behind Our Success, We Get in Early: BSX, AINV, PFE and SPF

Marketwired May 16, 2013

Special Situation Coming Soon, a Look Inside PFE, F, BSX and FB

Marketwired May 15, 2013

StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX

Accesswire May 15, 2013

Special Offer for Shareholders of PFE, DELL, GE and BSX

Marketwired May 14, 2013

Squawk Box Stocks Reports On: Nokia Corporation (NYSE: NOK), Advanced Micro Devices, Inc. (NYSE: AMD), Zynga, Inc. (NASDAQ: ZNGA), Pfizer Inc. (NYSE: PFE)

Marketwired May 14, 2013

Pfizer Announces 11 Abstracts for Tofacitinib to Be Presented at the European League Against Rheumatism (EULAR) 2013 Annual Meeting

Business Wire May 13, 2013

Before the Crowd, How We Found BAC, XOM, ACT and PFE

Marketwired May 11, 2013

Key to Success, How to Profit: PFE, INTC, DIS and PCLN

Marketwired May 10, 2013

Pain Therapeutics Files Form 8-K Regarding Correspondence From Pfizer, Inc.

Globe Newswire May 10, 2013

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

Business Wire May 8, 2013

Perfect Trade Setups, How to Play PFE, F, JNJ and INTC

Marketwired May 8, 2013

Accelrys and Pfizer Extend Agreement for Global Deployment of Scientific Innovation Lifecycle Management Software

PR Newswire May 7, 2013

Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation

Business Wire May 6, 2013

Facing Off Against Counterfeit Online Pharmacies: Pfizer Launches New Purchasing Website To Help Alleviate the Guesswork Around Buying Legitimate Viagra® (sildenafil citrate) Online

Business Wire May 6, 2013

The Reason It Trades, What's Moving S, PFE, JPM and AIG

Marketwired May 4, 2013

The Reason It Trades, What's Moving FB, PFE, VZ and GOOG

Marketwired May 2, 2013

Free Research Reports on IVZ, MGAM, PFE and VSH Issued by the Bedford Report

Marketwired May 1, 2013